Although initially designed as an inhibitor of the human immunodeficiency virus (HIV) protease, nelfinavir also inhibits Akt phosphorylation and activation [10], [36] that can radiosensitise tumours [10], [12], [37]. The gene discussed is AKT1; the disease is neoplasm.